These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18655096)

  • 21. The expression of BAFF-binding receptors is not altered in multiple sclerosis or myasthenia gravis.
    Thangarajh M; Kisiswa L; Pirskanen R; Hillert J
    Scand J Immunol; 2007 May; 65(5):461-6. PubMed ID: 17444957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
    Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
    Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
    Biernacki K; Antel JP; Blain M; Narayanan S; Arnold DL; Prat A
    Arch Neurol; 2005 Apr; 62(4):563-8. PubMed ID: 15824253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trypanosoma cruzi infection beats the B-cell compartment favouring parasite establishment: can we strike first?
    Acosta Rodriguez EV; Zuniga EI; Montes CL; Merino MC; Bermejo DA; Amezcua Vesely MC; Motran CC; Gruppi A
    Scand J Immunol; 2007; 66(2-3):137-42. PubMed ID: 17635791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
    Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
    Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.
    Elias D; Britton S; Aseffa A; Engers H; Akuffo H
    Vaccine; 2008 Jul; 26(31):3897-902. PubMed ID: 18554755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosis.
    Brod SA; Khan M; Bright J; Sriram S; Marshall GD; Henninger EM; Kerman RH; Wolinsky JS
    Ann Neurol; 1995 Apr; 37(4):546-9. PubMed ID: 7717692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
    Vanderlocht J; Hendriks JJ; Venken K; Stinissen P; Hellings N
    J Neuroimmunol; 2006 Aug; 177(1-2):189-200. PubMed ID: 16797728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-27 induces the production of IgG1 by human B cells.
    Boumendjel A; Tawk L; Malefijt Rde W; Boulay V; Yssel H; Pène J
    Eur Cytokine Netw; 2006 Dec; 17(4):281-9. PubMed ID: 17353163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
    Azoulay D; Mausner-Fainberg K; Urshansky N; Fahoum F; Karni A
    J Neuroimmunol; 2009 Jun; 211(1-2):114-9. PubMed ID: 19419774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.
    Pachner AR; Brady J; Narayan K
    J Neuroimmunol; 2007 Oct; 190(1-2):112-20. PubMed ID: 17919740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner.
    Guo S; Cobb D; Smeltz RB
    J Immunol; 2009 May; 182(10):6179-86. PubMed ID: 19414771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective potential beyond immunoregulation of helminth infection as a therapeutic target in multiple sclerosis.
    Zheng XP; Zhang HL; Li HF; Zhang MZ; Qiu W; Hu XQ
    Med Hypotheses; 2012 Jan; 78(1):95-7. PubMed ID: 22047987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis.
    Vanderlocht J; Hellings N; Hendriks JJ; Vandenabeele F; Moreels M; Buntinx M; Hoekstra D; Antel JP; Stinissen P
    J Neurosci Res; 2006 Apr; 83(5):763-74. PubMed ID: 16477612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.
    Desai F; Ramanathan M; Fink CS; Wilding GE; Weinstock-Guttman B; Awad AB
    Int Immunopharmacol; 2009 Jan; 9(1):153-7. PubMed ID: 19022404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis: an immune system activation disease.
    Macor S; Porrini AM; Giampietro A; Malatesta G; Gambi D
    Acta Neurol (Napoli); 1991 Dec; 13(6):590-6. PubMed ID: 1839591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
    J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
    Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
    J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.